Discontinuation report MINT-RIVASTIGMINE

Last updated on 2017-07-01 History
Report ID 13562
Drug Identification Number 02406985
Brand name MINT-RIVASTIGMINE
Common or Proper name Rivastigmine
Company Name MINT PHARMACEUTICALS INC
Active Ingredient(s) RIVASTIGMINE
Strength(s) 1.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size Blister pack of 56 capsules.
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-06-30
Remaining supply date 2017-06-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 1093 MEYERSIDE DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 1J6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2017-07-01 English Compare
v2 2017-06-21 French Compare
v1 2017-06-21 English Compare